Kure Cells is a biotechnology company developing rapid-manufacturing platforms for CAR-T and gene-modified cell therapies.
Kure Cells has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Kure Cells's investors include NantBio, Wa’ed Ventures, Qomel.
Kure Cells is headquartered in Oslo, Norway.
Kure Cells is a biotechnology company developing rapid-manufacturing platforms for CAR-T and gene-modified cell therapies.
Kure Cells is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kure Cells — Funding & Investors." VCBacked, October 23, 2025, https://www.vcbacked.co/company/kure-cells. Accessed October 6, 2026.
VCBacked. (2025). Kure Cells — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/kure-cells
{{cite web |title=Kure Cells — Funding & Investors |url=https://www.vcbacked.co/company/kure-cells |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated